Charting a faster path in drug discovery to create better lives for people around the world.
Location: United States
Total raised: $24M
Funding Rounds 1
| Date | Series | Amount | Investors |
| 23.07.2026 | Series A | $24M | JAZZ Ventu... |
Mentions in press and media 8
| Date | Title | Description |
| 27.07.2026 | Transcripta Bio Secures $24 Million to Accelerate AI Drug Discovery for Neurological Diseases | Transcripta Bio announced a significant $24 million capital raise. This funding, secured since its Series A, propels the company's AI-driven drug discovery platform. The Palo Alto firm targets neurological and neuromuscular diseases. New ca... |
| 23.07.2026 | Transcripta Bio Raises $24M in Funding | Transcripta Bio, a Palo Alto, CA-based AI-powered drug discovery company focused on neurological and neuromuscular diseases, raised $24M in funding. Backers included Mayo Clinic, Omnimed, JAZZ Venture Partners, BlueYard Capital, and a group... |
| 22.07.2026 | Transcripta Bio Announces $24 Million Funding | PALO ALTO, CA, Transcripta Bio, an AI-powered drug discovery company focused on neurological and neuromuscular diseases, announced it has raised $24 million since its Series A. >> Click here for more funding data on Transcripta Bio &... |
| 22.07.2026 | Transcripta Bio Raises $24 Million To Advance AI-Powered Neurological Drug Pipeline | Transcripta Bio has raised $24 million since its Series A financing to advance an AI-powered drug discovery platform focused on neurological and neuromuscular diseases. New investors Mayo Clinic and Omnimed joined existing backers JAZZ Vent... |
| 19.02.2026 | Verily Launches Self-Serve Access to Pre Platform with New Segmed and RefinedScience Datasets | What You Should Know The Launch: Alphabet’s Verily is lowering the barrier to entry for biomedical research by launching a free, self-serve “Standard tier” for its Pre precision health platform. The Tech: Researchers can now instantly acces... |
| 04.06.2024 | Meta Llama 3 on NVIDIA Boosts Healthcare Innovation with Open-Source AI | What You Should Know: – Meta’s open-source large language model, Meta Llama 3, is making significant waves in the healthcare and life sciences sectors. This cutting-edge technology, trained and optimized using NVIDIA’s accelerated computing... |
| 29.04.2024 | Transcripta Bio: $10 Million Raised To Speed Up Drug Discovery With Lower Risk | Transcripta Bio, a company focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel, announced its launch with $10 million in funding. Transcripta Bio co-founder, ... |
| - | Transcripta Bio | “Charting a faster path in drug discovery to create better lives for people around the world.” |